SMS Pharmaceuticals Ltd — Capital/Financing Update 2026

Feb 10, 2026

==> picture [241 x 158] intentionally omitted <==

Date: 10[th] February, 2026

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Subject: Report of the Monitoring Agency with respect to utilization of proceeds of the Preferential issue of warrants of SMS Pharmaceuticals Limited.

Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Monitoring Agency Report in respect of utilization of proceeds of the Preferential issue of convertible warrants for the quarter ended 31[st] December, 2025 issued by CARE Ratings Limited, Monitoring Agency.

We request to kindly take note of the same

Thanking you

Yours faithfully

For SMS Pharmaceuticals Limited

THIRUMALESH Digitally signed by THIRUMALESH TUMMA TUMMA Date: 2026.02.10 18:25:25 +05'30' Thirumalesh Tumma Company Secretary

Encl: a/a

==> picture [137 x 38] intentionally omitted <==

No. CARE/HRO/GEN/2025-26/1041

The Board of Directors

SMS Pharmaceuticals Limited

H No: 8-2-334/3 and 4, Plot No: 72, Opp SBI Executive Enclave, Road No: 5 Hyderabad Telangana - 500096

February 10, 2026

Dear Sir/Ma’am,

Monitoring Agency Report for the quarter ended 31/12/2025 - in relation to the share warrants – Private placement issue (whichever is applicable) of SMS Pharmaceuticals Limited (“the Company”)

We write in our capacity of Monitoring Agency for the Rights Issue for the amount aggregating to Rs. 114.30 crore of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.

In this connection, we are enclosing the Monitoring Agency Report for the quarter ended 31/12/2025 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated 27/03/2025.

Request you to kindly take the same on records.

Thanking you,

Yours faithfully,

==> picture [119 x 21] intentionally omitted <==

Y Tejeshwar Reddy

Associate Director tejeshwar.reddy@careedge.in

CARE Ratings Limited

==> picture [124 x 173] intentionally omitted <==

401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in

CIN-L67190MH1993PLC071691

Report of the Monitoring Agency

Name of the issuer: SMS Pharmaceuticals Ltd For quarter ended: 12/31/2025 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Nil

Declaration:

We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013.

The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.

We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.

Signature:

==> picture [119 x 21] intentionally omitted <==

Name and designation of the Authorized Signatory: Y Tejeshwar Reddy Designation of Authorized person/Signing Authority: Associate Director

CARE Ratings Limited

==> picture [124 x 173] intentionally omitted <==

401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in

CIN-L67190MH1993PLC071691

1) Issuer Details:

Name of the issuer : SMS Pharmaceuticals Ltd Name of the promoter : Ramesh Babu Potluri Industry/sector to which it belongs : Healthcare - Pharmaceuticals

2) Issue Details

Issue Period : 07/03/2024 to 13/03/2024 Type of issue (public/rights) : Private placement Type of specified securities : Convertible Share Warrants IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 114.30 crore

3) Details of the arrangement made to ensure the monitoring of issue proceeds:

Particulars	Particulars	Reply	Source of information / certifications considered by Monitoring Agency for preparation of report	Comments of the Monitoring Agency	Comments of the Board of Directors
Whether all utilization is as per the disclosures in the Offer Document?		Yes	Offer document (Form PAS-4 and EGM notice) and Chartered Accountant certificate*	Proceeds from the share warrants issue have been utilized for the objects mentioned in the offer document and EGM notice. As per the CA certificate, the utilized funds amounting to Rs. 80.93 Crore as of December 31, 2025. Unutilized funds continued to be deployed in working capital limits. Timely receipt of funds temporarily deployed for working capital into the MA account, as and when required, to meet the stated objects of the issue,remains important.	No comments received
Whether shareholder approval has been obtained in case of		No deviation	Management certificate	No deviations	No comments
	CARE Ratings Limited
	401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030 CIN-L67190MH1993PLC071691		Corporate Office :4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (E), Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in 3

Particulars	Reply	Source of information / certifications considered by Monitoring Agency for preparation of report	Comments of the Monitoring Agency	Comments of the Board of Directors
material deviations# from expenditures disclosed in the Offer Document?				received
Whether the means of finance for the disclosed objects of the issue have changed?	No	Offer document (Form PAS-4 and EGM notice) and Chartered Accountant certificate* and Management certificate	No	No comments received
Is there any major deviation observed over the earlier monitoringagencyreports?	No	Chartered Accountant certificate* and Management certificate	No deviations from earlier monitoring report issued forQ2FY26.	No comments received
Whether all Government/statutory approvals related to the object(s) have been obtained?	Yes	Management certificate	As per management confirmation, all necessary approvals required for the objects have been obtained from time to time.	No comments received
Whether all arrangements pertaining to technical assistance/collaboration are in operation?	Not applicable	Management Certificate	As per management confirmation, these arrangements are not applicable.	No comments received
Are there any favorable/unfavorable events affecting the viabilityof these object(s)?	No	Management Certificate	-	No comments received
Is there any other relevant information that may materially affect the decision makingof the investors?	No	Management certificate	-	No comments received

* Certificate from Suryanarayana & Suresh, Chartered Accountants (Statutory auditor) dated January 30, 2026.

Where material deviation may be defined to mean:

a) Deviation in the objects or purposes for which the funds have been raised

b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents.

4) Details of objects to be monitored:

(i) Cost of objects –

Sr.	Sr.	Item					Comments of the Board of Directors
	CARE Ratings Limited
	401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030 CIN-L67190MH1993PLC071691

No	Head	Source of information / certifications considered by Monitoring Agency for preparation of report	Original cost (as per the Offer Document) in Rs. Crore	Revised Cost in Rs. Crore	Comments of the Monitoring Agency	Reason for cost revision	Proposed financing option	Particulars of -firm arrangements made
1	Capital Expenditure	Chartered Accountant certificate*, Bank statements and Offer document (Form PAS-4 and EGM notice)	62.87	NA	NA	No comments received
2	Working Capital		40.00	NA	NA	No comments received
3	General Corporate Purposes		11.43	NA	NA	No comments received
Total			114.30

*Certificate from Suryanarayana & Suresh, Chartered Accountants (Statutory auditor) dated January 30, 2026.

(ii) Progress in the objects –

	Item Head	Source of information / certifications considered by Monitoring Agency for preparation of report	Amount as proposed in the Offer Document in Rs. Crore	Amount utilised in Rs. Crore	Amount utilised in Rs. Crore	Amount utilised in Rs. Crore	Total unutilis	Comments of the Monitoring Agency	Comments of the Board of Directors	Comments of the Board of Directors
				As at beginning of the quarter in Rs. Crore	During				Reasons for idle funds	Proposed course of action
					the	At the end	ed
					quarter in Rs. Crore	of the quarter in Rs. Crore	amoun t in Rs. Crore
1	Capital Expenditure	Chartered Accountant certificate*, Bank statements and Offer document (Form PAS-4 and EGM notice).	62.87	17.14	30.91	48.05	14.82	During Q3FY26, the Company utilised Rs.30.91 crore towards capital expenditure, with all payments to vendors routed through the MA account. Purchase orders have been provided on a sample basis for advance payments made towards capex.	The Company has temporarily deployed an amount of Rs.3334.7 lakhs towards working capital, pending its utilization, with the objective of reducing finance costs. The Audit
CARE Ratings Limited
401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030 CIN-L67190MH1993PLC071691						Corporate Office :4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (E), Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in 5

Sr. No	Item Head	Source of information / certifications considered by Monitoring Agency for preparation of report	Amount as proposed in the Offer Document in Rs. Crore	Amount utilised in Rs. Crore	Amount utilised in Rs. Crore	Amount utilised in Rs. Crore	Total unutilis	Comments of the Monitoring Agency	Comments of the Board of Directors	Comments of the Board of Directors
				As at beginning of the quarter in Rs. Crore	During				Reasons for idle funds	Proposed course of action
					the	At the end	ed
					quarter in Rs. Crore	of the quarter in Rs. Crore	amoun t in Rs. Crore
								In Q3FY26, out of total funds of Rs.61.9 crore utilized towards temporary deployment of working capital, funds amounting to Rs.22.1 crore were transferred back to monitoring account. These along with balance funds in MA were utilized towards payments to vendors for capex.	Committee advised that the said amount be re- transferred to the specified bank account, when required for project execution.
2	Working Capital		40.00	11.43	15.00	26.43	13.57	During Q3FY26, SMS transferred Rs. 15 crores from MA account to CC account towards workingcapital requirements.
3	General Corporate Purposes		11.43	0.00	6.45	6.45	4.98	During the quarter, Rs. 6.45 crores have been utilized towards registration and maintenance charges of corporate building under GCP which is as per the offer document. The payment is made from the CC account.
			114.30	28.57	52.36	80.93	33.37^

• Certificate from Suryanarayana & Suresh, Chartered Accountants (Statutory auditor) dated January 30, 2026.

^As per the offer document, Interim use of issue proceeds can be utilized for temporary deployment of working capital. Hence, the company had utilized the funds amounting to Rs.48.35 crore towards the same while the balance amount of Rs.0.03 crore is maintained in the monitoring account.

(iii) Deployment of unutilized proceeds:

CARE Ratings Limited

401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030

==> picture [30 x 21] intentionally omitted <==

Corporate Office :4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (E), Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in

==> picture [147 x 111] intentionally omitted <==

CIN-L67190MH1993PLC071691

6

Sr. No.	Type of instrument and name of the entity invested in	Amount invested	Maturity date	Earning	Return on Investment (%)	Market Value as at the end of quarter
1	Monitoringaccount,State bank of India	0.03	-	-	-	-
2	Temporarilydeployed towards workingcapital requirements	33.34	-	-	-	-

(iv) Delay in implementation of the object(s) –

	Completion Date	Completion Date	Delay (no. of	Comments of the Board of Directors	Comments of the Board of Directors
Objects	Asper the offer document	Actual	days/ months)	Reason of delay	Proposed course of action
Capital Expenditure	Within 24 months from receipt of funds for warrants i.e. Rs. 28.58 crores by March 14, 2026 Rs. 38.10 crores by March 25, 2027 Rs. 47.62 crores bySeptember 09,2027	Ongoing*	NA	No comments received
WorkingCapital		Ongoing*		No comments received
General Corporate Purposes		Ongoing*		No comments received

*While the outer timeline is 2 years from the date of receipt of funds for implementation of the above objects. A detailed schedule for the project implementation is not available and hence Care Ratings is unable to ascertain the actual progress towards the same.

5) Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document:

		Amount in Rs. Crore
			Source of information / certifications
Sr. No	Item Head^		considered by Monitoring Agency for	Comments of Monitoring Agency	Comments of the Board of Directors
			preparation of report
1	General Corporate Purposes	6.45	Chartered Accountant certificate*, Bank statements and offer document	Amount utilized for registration and maintenance expenses incurred for corporate building.	No comments received
	Total	6.45

* Certificate from Suryanarayana & Suresh, Chartered Accountants (Statutory auditor) dated January 30, 2026.

^ Section from the offer document related to GCP:

“General Corporate Purposes, which includes, inter alia, meeting ongoing general corporate exigencies and contingencies, expenses of the Company as applicable in such a manner and proportion as may be decided by the Board from time to time, and/or any other general purposes as may be permissible under applicable laws.”

==> picture [147 x 111] intentionally omitted <==

==> picture [30 x 21] intentionally omitted <==

CARE Ratings Limited

Corporate Office :4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (E), Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in

401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030

CIN-L67190MH1993PLC071691

7

Disclaimers to MA report:

a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as “Monitoring Agency/MA” ). The MA has taken utmost care to ensure accuracy and objectivity while developing this Report based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever.

b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate assessments. For the purpose of this Report, MA has relied upon the information provided by the management /officials/ consultants of the Issuer and third-party sources like statutory auditor appointed by the Issuer believed by it to be accurate and reliable.

c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any financial liabilities whatsoever to the users of this Report.

d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from sources it believes to be reliable, it does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives from statutory auditors, lawyers, chartered engineers or other experts, and relies on in its reports.

e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. As an example, the MA may rate the issuer or any debt instruments / facilities issued or proposed to be issued by the issuer that is subject matter of this report. The MA may receive separate compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors.

CARE Ratings Limited

401, Ashoka Scintilla, 3-6-520, Himayat Nagar, Hyderabad - 500 029 Phone: +91-40-4010 2030

==> picture [124 x 172] intentionally omitted <==

4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in • www.careedge.in

CIN-L67190MH1993PLC071691

8